1. Home
  2. VYNE vs SDOT Comparison

VYNE vs SDOT Comparison

Compare VYNE & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • SDOT
  • Stock Information
  • Founded
  • VYNE 2003
  • SDOT 2014
  • Country
  • VYNE United States
  • SDOT United States
  • Employees
  • VYNE N/A
  • SDOT N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • SDOT Restaurants
  • Sector
  • VYNE Health Care
  • SDOT Consumer Discretionary
  • Exchange
  • VYNE Nasdaq
  • SDOT Nasdaq
  • Market Cap
  • VYNE 7.9M
  • SDOT 8.0M
  • IPO Year
  • VYNE 2018
  • SDOT 2020
  • Fundamental
  • Price
  • VYNE $0.30
  • SDOT $0.91
  • Analyst Decision
  • VYNE Buy
  • SDOT
  • Analyst Count
  • VYNE 2
  • SDOT 0
  • Target Price
  • VYNE $8.00
  • SDOT N/A
  • AVG Volume (30 Days)
  • VYNE 1.9M
  • SDOT 139.7K
  • Earning Date
  • VYNE 11-06-2025
  • SDOT 08-14-2025
  • Dividend Yield
  • VYNE N/A
  • SDOT N/A
  • EPS Growth
  • VYNE N/A
  • SDOT N/A
  • EPS
  • VYNE N/A
  • SDOT 0.61
  • Revenue
  • VYNE $476,000.00
  • SDOT $667,695,000.00
  • Revenue This Year
  • VYNE N/A
  • SDOT $12.76
  • Revenue Next Year
  • VYNE N/A
  • SDOT $5.54
  • P/E Ratio
  • VYNE N/A
  • SDOT $1.18
  • Revenue Growth
  • VYNE N/A
  • SDOT 7.00
  • 52 Week Low
  • VYNE $0.29
  • SDOT $0.84
  • 52 Week High
  • VYNE $4.30
  • SDOT $5.70
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 28.46
  • SDOT 41.60
  • Support Level
  • VYNE $0.32
  • SDOT $0.89
  • Resistance Level
  • VYNE $0.33
  • SDOT $0.95
  • Average True Range (ATR)
  • VYNE 0.02
  • SDOT 0.05
  • MACD
  • VYNE 0.03
  • SDOT 0.01
  • Stochastic Oscillator
  • VYNE 11.44
  • SDOT 50.00

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About SDOT Sadot Group Inc.

Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.

Share on Social Networks: